Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
04/05/2001 | WO2001023411A2 Incorporation of modified nucleotides by archaeon dna polymerases and related methods |
04/05/2001 | WO2001023410A2 Drug target isogenes: polymorphisms in the interleukin 13 gene |
04/05/2001 | WO2001023409A2 38 human secreted proteins |
04/05/2001 | WO2001023402A1 43 human secreted proteins |
04/05/2001 | WO2001023401A2 Use of codon-varied oligonucleotide synthesis for synthetic sequence recombination |
04/05/2001 | WO2001023082A2 Biomolecular attachment sites on microelectronic arrays |
04/05/2001 | WO2001023004A1 Replication selective adenoviruses for use in cancer therapy |
04/05/2001 | WO2001023001A2 Rapid peg-modification |
04/05/2001 | WO2001022990A2 Methods related to immunostimulatory nucleic acid-induced interferon |
04/05/2001 | WO2001022987A1 Trail: an inhibitor of autoimmune inflammation and cell cycle progression |
04/05/2001 | WO2001022972A2 Immunostimulatory nucleic acids |
04/05/2001 | WO2001022922A2 Engineering antibodies that bind irreversibly |
04/05/2001 | WO2001022921A2 Prevention of atherosclerosis and undesired blood clotting by reducing von willebrand factor |
04/05/2001 | WO2001022916A2 Novel hev antigenic peptide and methods |
04/05/2001 | WO2001022811A1 Transgenic animal expressing a multiple mutated form of presenilin 1 |
04/05/2001 | WO2001022810A2 Transgenic animals expressing von willebrand factor (vwf) and vwf-related polypeptides |
04/05/2001 | WO2001022806A1 Expression of phytase in plants as a method of modifying plant productivity |
04/05/2001 | WO2001011369A8 Cancer treatments and diagnostics utilizing rad51 related molecules and methods |
04/05/2001 | WO2001007915A3 Layered device with capture regions for cellular analysis |
04/05/2001 | WO2001007573A8 Electron donor system for enzymes and its use for the biochemical conversion of substrates |
04/05/2001 | WO2001006015A8 NOVEL GLYCOSYL SULFOTRANSFERASES GST-4α, GST-4β, AND GST-6 |
04/05/2001 | WO2001000786A3 Bacteriophage library useful for typing bacteria and system and method utilizing same |
04/05/2001 | WO2000075343A3 ENGINEERING β-KETOACYL ACP SYNTHASE FOR NOVEL SUBSTRATE SPECIFICITY |
04/05/2001 | WO2000073450A3 Cytoskeleton-associated proteins |
04/05/2001 | WO2000073334A3 Human sorting nexins |
04/05/2001 | WO2000072023A3 Diagnosis and treatment of atherosclerosis and coronary heart disease |
04/05/2001 | WO2000071573A3 Immunogenic peptides derived from mage and the use thereof |
04/05/2001 | WO2000070059A3 Signal transduction genes and methods of use |
04/05/2001 | WO2000070058A3 Plant cellulose synthase genes |
04/05/2001 | WO2000069455A3 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus |
04/05/2001 | WO2000068420A3 Identification of candida albicans essential fungal specific genes and use thereof in antifungal drug discovery |
04/05/2001 | WO2000066788A3 Polynucleotide probes for detection and quantitation of staphylococcus |
04/05/2001 | WO2000066752A3 Gene construct for prodrug activation encoding a heterologous, glycosylphophati dylinositol-modified carboypeptidase g2 and a cell surface targettng signal peptide |
04/05/2001 | WO2000065027A3 Human gil-19/ae289 proteins and polynucleotides encoding same |
04/05/2001 | WO2000061617A3 Transiently immortalized cells for use in gene therapy |
04/05/2001 | WO2000060113A3 Transposon-based genetic marker |
04/05/2001 | WO2000060087A3 Cyclin dependent kinase inhibitor genes from plants |
04/05/2001 | WO2000060051A8 Arpe-19 as a platform cell line for encapsulated cell-based delivery |
04/05/2001 | WO2000056891A3 Human transmembrane proteins |
04/05/2001 | WO2000055368A3 Probe/mobility modifier complexes for multiplex nucleic acid detection |
04/05/2001 | WO2000055343A3 Retrovirus producting cells utilizing a high multiplicity of transduction |
04/05/2001 | WO2000053789A3 Retroviral expression vectors on the basis of herv- long terminal repeat sequences |
04/05/2001 | WO2000053738A8 Methods and compositions for regulating memory consolidation |
04/05/2001 | WO2000052205A3 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE |
04/05/2001 | WO2000052164A3 Potassium channel molecules and uses therefor |
04/05/2001 | WO2000050644A3 Methods for purifying dna using immobilized capture probes |
04/05/2001 | WO2000031257A9 Novel serine protease bssp6 |
04/05/2001 | WO2000031254A9 Apoptosis-inducing factor |
04/05/2001 | WO2000029578A9 Cloning and characterization of two m-rna transcription factors |
04/05/2001 | WO2000020450A9 Calcium channel alpha-2/delta gene |
04/05/2001 | WO1999060126A9 Protein z-dependent protease inhibitor |
04/05/2001 | WO1999049022A9 Phytase variants |
04/05/2001 | WO1996008567B1 Microorganisms and methods for overproduction of dahp by cloned pps gene |
04/05/2001 | US20010000149 Solid medium and process for the storage and rapid purification of nucleic acid |
04/05/2001 | DE19948679A1 Nucleic acid sequences from human endothelial cells, useful for gene therapy of angiogenesis and for identifying antiangiogenic agents |
04/05/2001 | DE19947456A1 New synthetic derivatives of the C-peptide of proinsulin, useful in the preparation of human insulin or insulin analogs in high yield |
04/05/2001 | DE19947010A1 Das Gen PRV-1 und dessen Verwendung The PRV-1 gene and its use |
04/05/2001 | DE19945964A1 Verfahren und Nukleinsäuren zum Nachweis von brauereirelevanten Mikroorganismen Method for the detection of nucleic acids and brewery relevant microorganisms |
04/05/2001 | DE19945916A1 Nukleinsäuremoleküle zum Nachweis von Bakterien und phylogenetischen Einheiten von Bakterien Nucleic acid molecules for the detection of bacteria and phylogenetic units of bacteria |
04/05/2001 | DE19943177A1 Verfahren zur Herstellung von aktiven Serienproteasen und inaktiven Varianten A process for the production of active and inactive variants series proteases |
04/05/2001 | CA2811455A1 Highly conserved genes and their use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes and amplification primers to rapidly detect and identify algal, archaeal, bacterial, fungal and parasitical microorganisms from clinical specimens for diagnosis |
04/05/2001 | CA2397786A1 Alzheimer's disease secretase, app substrates therefor, and uses therefor |
04/05/2001 | CA2393223A1 Multiplex pcr for detecting ehec infections |
04/05/2001 | CA2390716A1 Process for enhancing electric field-mediated delivery of biological materials into cells |
04/05/2001 | CA2389203A1 Human secretory molecules |
04/05/2001 | CA2388492A1 Method and device for detecting a molecular recognition reaction |
04/05/2001 | CA2388461A1 Highly conserved genes and their use to generate probes and primers for the detection of microorganisms |
04/05/2001 | CA2388055A1 Immunostimulatory nucleic acids |
04/05/2001 | CA2387971A1 Transacylases of the paclitaxel biosynthetic pathway |
04/05/2001 | CA2387702A1 The prv-1 gene and use thereof |
04/05/2001 | CA2386622A1 Biomolecular attachment sites on microelectronic arrays |
04/05/2001 | CA2386346A1 Novel polynucleotides and polypeptides encoded thereby |
04/05/2001 | CA2386213A1 Human kinase proteins and polynucleotides encoding the same |
04/05/2001 | CA2386197A1 Complementarity determining region-grafted antibody against ganglioside gd3 and derivative of antibody against ganglioside gd3 |
04/05/2001 | CA2386077A1 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof |
04/05/2001 | CA2386032A1 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
04/05/2001 | CA2386029A1 P-glycoproteins from macaca fascicularis and uses thereof |
04/05/2001 | CA2386013A1 Enzyme which cleaves ester groups and which is derived from thermomonospora fusca |
04/05/2001 | CA2386002A1 Trail: an inhibitor of autoimmune inflammation and cell cycle progression |
04/05/2001 | CA2385888A1 Engineering antibodies that bind irreversibly |
04/05/2001 | CA2385887A1 Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors |
04/05/2001 | CA2385884A1 26 human secreted proteins |
04/05/2001 | CA2385883A1 Human carboxypeptidases and polynucleotides encoding the same |
04/05/2001 | CA2385880A1 Novel human organic anion transporter-like proteins and polynucleotides encoding the same |
04/05/2001 | CA2385743A1 Factors having prion-binding activity in serum and plasma and agents to detect transmissible spongiform encephalopathitis |
04/05/2001 | CA2385633A1 Paralogue of a head trauma induced cytoplasmatic calcium binding protein |
04/05/2001 | CA2385609A1 Creation of variable length and sequence linker regions for dual-domain or multi-domain molecules |
04/05/2001 | CA2385580A1 Expression of phytase in plants as a method of modifying plant productivity |
04/05/2001 | CA2385169A1 43 human secreted proteins |
04/05/2001 | CA2385162A1 Compositions and methods for altering gene expression |
04/05/2001 | CA2385015A1 Methods of producing cloned and transgenic mammals |
04/05/2001 | CA2384981A1 P-glycoproteins and uses thereof |
04/05/2001 | CA2384814A1 Methods for rapid peg-modification of viral vectors, compositions for enhanced gene transduction, compositions with enhanced physical stability, and uses therefor |
04/05/2001 | CA2384723A1 Vaccine |
04/05/2001 | CA2384662A1 41 human secreted proteins |
04/05/2001 | CA2384659A1 37 human secreted proteins |
04/05/2001 | CA2384584A1 38 human secreted proteins |
04/05/2001 | CA2384382A1 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus |
04/05/2001 | CA2383982A1 Transgenic animal expressing a multiple mutated form of presenilin 1 |
04/05/2001 | CA2382808A1 22196, a novel human aminopeptidase |